+

RU2018137034A3 - - Google Patents

Download PDF

Info

Publication number
RU2018137034A3
RU2018137034A3 RU2018137034A RU2018137034A RU2018137034A3 RU 2018137034 A3 RU2018137034 A3 RU 2018137034A3 RU 2018137034 A RU2018137034 A RU 2018137034A RU 2018137034 A RU2018137034 A RU 2018137034A RU 2018137034 A3 RU2018137034 A3 RU 2018137034A3
Authority
RU
Russia
Application number
RU2018137034A
Other versions
RU2018137034A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018137034A publication Critical patent/RU2018137034A/ru
Publication of RU2018137034A3 publication Critical patent/RU2018137034A3/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/10011Circoviridae
    • C12N2750/10034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
RU2018137034A 2016-03-23 2017-03-22 Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae RU2018137034A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161997.8 2016-03-23
EP16161997 2016-03-23
PCT/EP2017/056831 WO2017162741A1 (en) 2016-03-23 2017-03-22 A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022116197A Division RU2022116197A (ru) 2016-03-23 2017-03-22 Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae

Publications (2)

Publication Number Publication Date
RU2018137034A RU2018137034A (ru) 2020-04-23
RU2018137034A3 true RU2018137034A3 (ru) 2020-06-26

Family

ID=55589754

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018137034A RU2018137034A (ru) 2016-03-23 2017-03-22 Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae

Country Status (7)

Country Link
US (1) US20190105385A1 (ru)
EP (1) EP3432919A1 (ru)
JP (1) JP6907227B2 (ru)
CN (1) CN108697782A (ru)
BR (1) BR112018069100A2 (ru)
RU (1) RU2018137034A (ru)
WO (1) WO2017162741A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111447948A (zh) * 2017-12-04 2020-07-24 英特维特国际股份有限公司 具有复制子颗粒和油佐剂的疫苗
CA3085535A1 (en) * 2017-12-22 2019-06-27 Hipra Scientific, S.L.U. Intradermal combination vaccine against mycoplasma and porcine circovirus
JP2022548001A (ja) * 2019-09-12 2022-11-16 インターベット インターナショナル ベー. フェー. 皮内投与用混合ワクチン
BR112022020620A2 (pt) * 2020-04-20 2022-11-29 Intervet Int Bv Vacina para proteger contra mycoplasma hyopneumoniae

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
MXPA06000942A (es) * 2003-07-24 2006-03-30 Merial Ltd Nuevas formulaciones de vacunas.
NZ550152A (en) * 2004-04-05 2009-04-30 Pfizer Prod Inc Microfluidized oil-in-water emulsions and vaccine compositions
WO2006074986A2 (en) 2005-01-13 2006-07-20 Boehringer Ingelheim Vetmedica Gmbh Prrs vaccines
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
AR054822A1 (es) * 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
CN101277717A (zh) 2005-09-09 2008-10-01 英特威国际有限公司 Pcv-2疫苗
EP2275130A3 (en) 2005-12-29 2011-03-23 Boehringer Ingelheim Vetmedica, Inc. PCV2 ORF2 immunogenic composition
MX2009006066A (es) 2006-12-15 2009-06-17 Boehringer Ingelheim Vetmed Tratamiento de cerdos con el antigeno pcv.
TWI449533B (zh) * 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌(Lawsonia intracellularis)、豬肺炎黴漿菌(Mycoplasma hyopneumoniae)及豬環狀病毒(Porcine circo virus)用疫苗
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
JP6460792B2 (ja) * 2011-09-09 2019-01-30 ナノバイオ コーポレーション ナノエマルション呼吸器合胞体ウイルス(rsv)サブユニットワクチン
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN104043118A (zh) * 2013-03-11 2014-09-17 普莱柯生物工程股份有限公司 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用
CN103263666B (zh) * 2013-05-24 2019-07-16 北京大北农科技集团股份有限公司动物医学研究中心 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法
US10130699B2 (en) * 2013-12-03 2018-11-20 Intervet Inc. Vaccine against Lawsonia intracellularis and porcine circovirus 2

Also Published As

Publication number Publication date
RU2018137034A (ru) 2020-04-23
EP3432919A1 (en) 2019-01-30
US20190105385A1 (en) 2019-04-11
JP6907227B2 (ja) 2021-07-21
BR112018069100A2 (pt) 2019-01-29
WO2017162741A1 (en) 2017-09-28
JP2019509300A (ja) 2019-04-04
CN108697782A (zh) 2018-10-23

Similar Documents

Publication Publication Date Title
BR122021012469A2 (ru)
RU2018137034A3 (ru)
BR112019008315A2 (ru)
BR112019009373A2 (ru)
BE2016C036I2 (ru)
CN303540675S (ru)
CN303540561S (ru)
CN303536658S (ru)
CN303537400S (ru)
CN303537428S (ru)
CN303537757S (ru)
CN303537825S (ru)
CN303537828S (ru)
CN303538480S (ru)
CN303538529S (ru)
CN303538548S (ru)
CN303539285S (ru)
CN303539320S (ru)
CN303541783S (ru)
CN303539632S (ru)
CN303541578S (ru)
CN303540616S (ru)
CN303540620S (ru)
CN303540622S (ru)
CN303543628S (ru)
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载